MultiCell Technologies, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MultiCell Technologies, Inc.

MCET 0.00001000

0.0%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Tradenride	10/29/2005 11:14:06 AM
	Read Replies (1) of 237

RWS, the US already has a vaccine, we just need Chiron to make enough. All this talk about MCET curing the strain is hogwash IMO Q: What about a vaccine, is there anything on the horizon that would be viable? -- NPR's Melissa Block A: The U.S. government, the Department of Health and Human Services through the NIH, isolated an H5N1 virus about a year and a half ago from a North Vietnamese patient who was infected from a chicken, made a vaccine and began vaccine trials. The first stage of which shows the vaccine is safe and actually capable of inducing an immune response that is predicted to be protective against this particular virus. One of the sobering issues associated with this is that the dose required to induce that level of immune response is considerably higher than the standard dose that we use with seasonal flu, which compounds a problem that exists with production capacity. So it's less an issue of, "do we or do we not have a vaccine," than it is, "can we produce enough vaccine to make it available for virtually any one who needs it?" And right now the answer to that is no, and that's something we're working on. npr.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next